INTRODUCTION:

Bioavailability is the rate at which a substance or medication arrives at its planned natural objective, critical in pharmacokinetics. It is affected by organization course and portion, with lower bioavailability requiring bigger dosages. of further developed treatment choices^1-5.

Rheumatoid joint pain, a persistent provocative issue, can harm body frameworks and cause actual handicaps, regardless

· Delicate, warm, enlarged joints

· Joint firmness that is normally more awful in the mornings and after latency

· Weakness, fever and loss of hunger

Symptoms:

These symptoms are clues to RA:^6-8

· Joint torment, delicacy, expanding or solidness that goes on for quite some time or longer.

· Morning firmness that goes on for 30 minutes or longer.

· More than one joint is impacted.

· Little joints (wrists, certain joints in the hands and feet) are ordinarily impacted first.

Strategies like micronization, substance alteration, pH change, strong scattering, Complexation, co-dissolvability, and hydrotropy can further develop solubilization of ineffectively water-solvent drugs, especially those with low water dissolvability.⁹

Biopharmaceutical Arrangement Framework:

Fig. 1: BCS Arrangement

The Biopharmaceutics Arrangement Framework classifies drugs in light of penetrability and solvency, restricting expectations. It utilizes an opening from the USP and intravenous shot to decide gastrointestinal penetrability arrangement. 85% of well known meds are orally taken.^10-11

Fig. 2: Biopharmaceutical Classification

• Class I: excellent solubility and permeability

• For instance, Metoprolol and paracetamol ¹²

• These substances are readily absorbed, and their rate of absorption typically exceeds that of excretion.

• Class II: low solubility and high permeability

• For instance, glibenclamide, aceclofenac, bicalutamide, and ezetimibe

• Their solvation rate restricts those products' bioavailability. There is a correlation between the in vitro solvation and the in vivo bioavailability.

• Class III: low solubility and high permeability

• For instance, glibenclamide, aceclofenac, bicalutamide, and ezetimibe

• Their solvation rate restricts those products' bioavailability. There is a correlation between the in vitro solvation and the in vivo bioavailability.

• Class IV: low solubility and permeability

• Consider Bifonazole.

• These substances are not very bioavailable. They typically absorb poorly through the intestinal mucosa, so significant variability is to be expected.

Importance of Bioavailability:

Bioavailability is a basic calculate the viability of prescriptions and medications since it decides the extent of the controlled portion that arrives at the circulatory system and is accessible to create the ideal restorative outcome. Here are a few key motivations behind why bioavailability is significant in the area of pharmacology:

Adequacy: Drugs should be assimilated and appropriated in the body to be viable. Low bioavailability can prompt deficient medication levels, diminishing the restorative reaction.¹³

Dosing:

Understanding bioavailability helps in deciding the suitable dose to accomplish the ideal medication fixation in the body.

Consistency:

It guarantees consistency in drug execution, which is fundamental for keeping up with the ideal helpful impact after some time.

Cost-effectiveness:

Proficient medication conveyance frameworks that improve bioavailability can diminish the amount of medication expected for a similar impact, possibly bringing down creation costs.

Safety:

High bioavailability can help abstain from going too far, diminishing the gamble of antagonistic impacts.

Formulation:

Bioavailability contemplations impact drug definition, prompting the improvement of more powerful conveyance techniques like broadened discharge plans or novel medication conveyance frameworks.¹⁴

Generic Substitution:

Bioequivalence reads up are critical for nonexclusive medications to guarantee they have comparable bioavailability to the first marked drugs.

Food Interactions:

Understanding what food means for drug ingestion is essential to upgrade drug organization guidelines.

Bioavailability Enhancement Techniques:

There are various strategies accessible to build the solvency of prescriptions that are inadequately solvent. These strategies fall into the accompanying classes:

Fig. 3: Bioavailability Improvement Customary Strategies

Customary Techniques:

Traditional techniques include:

1. Use of co-surfactants

2. Hydrotropy method

3. Micronization

4. Use of surfactants

5. Use of metastable polymorphs

6. Solvent deposition

7. Precipitation

8. Use of prodrug

9. Use of Salt forms

10. Size reduction technology

11. Porous Microparticle Technology

12. Use of Hydrates or Solvates

12. Molecular encapsulation withcyclodextrin

13. Solid dispersion

14. Eutectic mixtures

15. Solid solutions

16. Amorphous forms

Use of co-surfactants:

Co dissolvability is a cycle where a water-miscible or somewhat miscible natural dissolvable is added to a nonpolar medication, decreasing its solvency. Co-solvents, like 4, 5 Ethanol, propylene glycol, and Stake 300, can be utilized for oral and parenteral medication organization.

Hydrotrophy method:

Hydrotropy is a solvency strategy that builds the dissolvability of a subsequent solute by adding a high grouping of added substances, basically connected with Complexation, a frail cooperation between inadequately solvent medications and hydrotropic specialists.

Advantages:

· Hydrotrophy has a high selectivity and doesn't need emulsification, and its dissolvable

· Hydrotrophy has a high selectivity and doesn't need emulsification, and its dissolvable nature is free of pH.

· It needn't bother with the utilization of natural solvents, or the arrangement of an emulsion framework.¹⁴

Micronization:

Due to the gigantic surface made, the molecule size decrease method works on the solvency and pace of disintegration of medications that are inadequately solvent in water. The cycle involves decreasing the strong medication molecule size to 1 to 10 microns; for the most part by shower drying or utilizing air weakening procedures like rotor stator colloid factories, liquid energy plants, stream plants, etc.

Use of surfactants:

Surfactants have both polar and non-polar finishes, making them amphiphilic in nature. By empowering the wetting and entrance of disintegration liquid into the strong medication particles, the surface-dynamic specialist fundamentally builds the pace of disintegration.

Use of metastable polymorphs:

A medication's glasslike state might affect its immersion solvency and, therefore, its disintegration. At the point when a medication shows polymorphism, its metastable polymorph is more solvent than its steady polymorph.¹⁵

Solvent deposition:

This cycle includes dissolving the ineffectively fluid dissolvable medication in a natural dissolvable, like liquor, and afterward permitting the dissolvable to vanish prior to storing the medication on an idle, hydrophilic, strong lattice, like starch or microcrystalline cellulose.

Precipitation:

To encourage the medication in nanosized particles, this strategy includes dissolving the ineffectively watery dissolvable medication in a suitable natural dissolvable and rapidly blending it in with a non-dissolvable. "Hydrosol" is one more name for the pre-arranged item. For intravenous organization, hydrosols are colloidal fluid suspensions that contain drug nanoparticles of inadequately water-solvent meds.

Use of prodrug:

A dormant medication forerunner that has gone through synthetic change to deliver the pharmacologically dynamic parent compound through biotransformation is known as a prodrug.

Use of Salt forms:

Salt development is the favored procedure for expanding retention in compounds with useful gatherings. Salts of inadequately solvent substances normally break down in the GIT all the more rapidly, improving assimilation.

Size reduction technology:

Among the more convoluted details are nano plans. To save the nature and qualities of the nanoparticles, the medication particles should not exclusively be made nanoscale, yet additionally painstakingly settled and ready.

Porous Microparticle Technology:

An unfortunate water-solvent medication is implanted in microparticles with a framework that is permeable and water dissolvable, likened to a wipe. The network disintegrates when joined with water, wetting the medicine and abandoning a suspension of rapidly dissolving drug particles. This is HDDSTM (Hydrophobic Medication Conveyance Framework's) essential innovation.

Use of Hydrates or Solvates:

Both stoichiometric and non-stoichiometric adducts, for example, considerations, which include dissolvable atoms caught inside the gem cross section, can be available in glasslike compounds. A stoichiometric adduct, otherwise called "Solvate, " is a sub-atomic complex that has incorporated the particles of the solidifying dissolvable into specific areas inside the gem grid. The complex is alluded to as a "Hydrate" when water is the included dissolvable. The expression "anhydrous" alludes to a compound that has no water in its precious stone construction.

Molecular encapsulation with cyclodextrin:

A few unique particles are microscopically epitomized in oligosaccharides produced using starch utilizing beta-cyclodextrin. Their capacity to work as a sub-atomic holder by trapping visiting particles in their inner pit is exceptional to them because of their sub-atomic design and shape. Hence, cyclodextrin makes inadequately dissolvable medications more solvent in water, which upgrades their bioavailability.

Solid dispersion:

A strong scattering is an assortment of strong items comprised of at least two particular parts, generally a hydrophilic medication and a hydrophobic grid (transporter). It is workable for the grid to be translucent or shapeless.

One of the accompanying components makes sense of how sleek scatterings accelerate the rate at which sedates that are not extremely water-solvent break down:

Reduction in particle size

· Improvement in wettability and dispersibility

· Changing crystalline form of drug to amorphous form

· Reduction in aggregation and agglomeration drug

Strong scattering and strong arrangement/eutectics vary in drug precipitation, with shapeless structures being liked. Co-vanishes or co-hastens are normal terms. Notwithstanding, high handling costs, dissolvable prerequisites, and dissolvable evacuation issues are difficulties. Transporters utilized are like smooth materials in eutectics or strong arrangements.

Eutectic mixtures:

Eutectics are combinations of two glasslike parts that solubilize rapidly because of the disintegration of the dissolvable transporter, similar to acetaminophen and headache medicine in drugs. They speed up physiological assimilation and lessen drug molecule accumulation and agglomeration.

Solid solutions:

Strong arrangements are paired frameworks with a strong dissolvable and solute, with higher solvency and quicker disintegration than eutectics. They are regularly made utilizing the combination technique. Glass arrangements are homogenous, straightforward, and fragile. Two strategies further develop solvency and speed of disintegration: solvent transporters break up rapidly in water, and dissolvable transporters break up rapidly in the strong state.

Amorphous forms:

Iotas or particles are organized haphazardly and have a higher thermodynamic energy in shapeless structures than in comparing translucent structures. Both solvency and pace of disintegration are commonly higher.

Newer and Novel Techniques:

Fig. 4: New and Novel Techniques of Bioavailability Enhancement

Newer and novel drug delivery technologies developed in recent years for solubility enhancement of insoluble drugs are

1. Size reduction technologies

2. Nanoparticle Technology

3. Nanocrystals Technology

4. Nanosuspension

5. Cryogenic Technology

6. Supercritical Technology

7. Lipid based delivery system

8. Microemulsion Technology

9. Self-Dispersing Lipid Formulation (SDLF)

10. Micellar technologies

11. Mixed Micelle

12. Polymeric Micelle

13. Porous Microparticle technology

14. Self-emulsifying drug delivery system

15. Cryogenic techniques

16. Co-crystallization

17. Supercritical nanotechnology

18. Solid-lipid nanoparticles

19. Complexation

Size reduction technology:

Among the more multifaceted plans are nanoformulations. The drug particles should be made nanoscale, yet they furthermore should be ready and settled stringently to safeguard the characteristics and nature between the nanoparticles.

Microemulsion technology:

Interfacial movies of surface-dynamic atoms balance out miniature emulsions, which are isotropically clear, thermodynamically stable scatterings of two immiscible fluids. Oil, water, surfactant, and co-surfactant are basically fomented to make the miniature emulsions. Interfacial pressure is brought down to very low and now and again even fleeting negative qualities when the co-surfactant and surfactant are joined.

Self-dispersing liquid formulation:

The medication is blended in with oil and a surfactant combination to make the SDLFs. When joined with a watery climate, they emulsify.

Micellar Technologies:

· Mixed Micelles:

Particles that can bring down a dissolvable's surface pressure, for example, those that are amphiphilic, ionic, anionic, or ampholytic, regularly structure micelles over a basic focus. Just over a particular solute focus, known as the basic micellar fixation (CMC), and at arrangement temperatures higher than the basic micellar temperature (CMT), can micellar development happen.

· Polymeric micelles:

Polymeric micelles are little supramolecular center shell structures made of amphiphilic polymers. The block copolymers Pluronics, poly (ethylene glycol) (Stake)- phospholipid forms, Stake b-poly (ester), and Stake b-poly (L-amino acids) are used to shape polymeric micelles. The micelles those are polymeric and nonpolymeric

Porous microparticle technology:

The drug, which isn't very water solvent, is encased in microparticles with a network that is permeable and water dissolvable. The grid breaks down when joined with water, wetting the prescription and creating a suspension of rapidly dissolving drug particles. This is HDDSTM (Hydrophobic Medication Conveyance Framework's) essential innovation.

Solid dispersion system:

Strong scattering alludes to the development of eutectic combinations of medications with water-dissolvable transporters, regularly comprising of a hydrophilic framework and a hydrophobic medication, and can be conveyed in glasslike, shapeless, or sub-atomic structures.

Types of Solid Dispersion System:

In light of their atomic game plan, six distinct kinds of strong scatterings can be recognized

Simple eutectic mixtures: A combination of An and B with piece E takes shape out at the same time, making a strong eutectic blend. This interaction includes cooling a co-dissolve of the two mixtures, delivering fine gems of the medication. The enormous surface region helps disintegration rate and bioavailability, as displayed in the stage chart.

Solid Solution:

· Continuous Solid Solution:

All proportions of the parts in a persistent strong arrangement are miscible. This shows, in principle, that there is a more grounded connection between the two parts than there is between the particles of every individual part.

· Discontinuous Solid Solution:

That's what goldberg proposes "strong arrangement" ought to possibly be utilized when shared dissolvability surpasses 5% between two parts. The medication part's portion and solvency decide whether a strong arrangement can be utilized as a measurement procedure.

Substitutional Crystalline Solid Solution:

In translucent strong arrangements, the solute particles can either occupy the spaces between the dissolvable particles or go about as a substitute for the dissolvable particles in the gem grid. Just in situations where there is a size contrast between the solute and dissolvable particles of under 15% is replacement practical.

Interstitial Crystalline Solid Solution:

The broke down particles in interstitial strong arrangements make up for the shortcomings made by the dissolvable atoms in the precious stone grid. To consume interstitial space, solute particles should have a sub-atomic breadth no more prominent than 0.59 of the dissolvable atoms' sub-atomic width. Moreover, something like 20% of the dissolvable ought to be contained in the volume of the solute atoms.

Amorphous solid solution:

The primary endeavor to further develop drug disintegration properties involving griseofulvin in citrus extract included shaping a shapeless strong arrangement, with urea, sugars, and natural polymers like PVP, Stake, and cellulose subsidiaries utilized as transporters.

Glass Solution and Glass Suspension:

A smooth dissolvable disintegrate a solute in a homogenous, polished framework known as a glass arrangement. Generally, a sudden extinguish of the dissolve creates the smooth or glassy state. Straightforwardness and fragility are its characterizing attributes underneath the glass change temperature (Tg). It mellow progressively and constantly when warmed, not liquefying totally on the double.

Self-Emulsifying Drug Delivery Systems (SEDDS):

Fluid arrangements, like SEDDS, are utilized to further develop bioavailability of inadequately solvent, exceptionally permeable medication particles by melting hydrophobic ones in the gastrointestinal parcel lumen, bringing about a self-emulsification in situ emulsion, which has been connected to a few in vivo properties.³¹

· Self-nano emulsifying drug delivery system (SNEDDS)

· Self-micro emulsifying drug delivery system (SMEDDS)

Ingredients for a self-emulsifying medication delivery system:

Active Pharmaceutical Ingredients (APIs):

To work on the dissolvability of prescriptions with low watery solvency, self-emulsifying drug conveyance frameworks are ordinarily used; BCS class II meds, like itraconazole, naproxen, vitamin E, mefenamic corrosive, danazol, nifedipine, simvastatin, and so on, are by and large liked.

Excipients used in SEDDS:

· Oils

· Surfactants

· Co-surfactants

· Enhancers

· Polymers

· Antioxidant agents

Table 1: Parenteral Microemulsion Products Were Marketed

Drug	Therapeutic area	Product name
Cyclosporine A	Immunomodulation	Restasis
Diazepam	Sedation	Diazemuls
Dexamethasone palmitate	Corticosteroid	Limethason
Etomidate	Amastjesia	Etomidat
Flurbiprofine	Analgesia	Fluosol – DA
Propofol	Anaesthesia	Propofol diprivan
Prostaglandin E-1	Vasodilator	Liple
Vitamin A, D, E, K	Nutrition	Vitalipid

Cryogenic techniques:

By utilizing cryogenic strategies, which produce an indistinct medication with a high porosity level at low temperatures, medications can be made to break down more rapidly. After the powder has been cryopreserved, it very well may be dried by vacuum, shower, or lyophilization. Figure 3 notices various cryogenic strategies.^32,33,34

Fig. 5: Various Cryogenic Methods

Co-crystallization:

Co-precious stones are intricate supramolecular materials that can determine drug dissolvability, bioavailability, and soundness issues without changing their synthetic design. They change sub-atomic associations and creation of drug compounds, boosting remedial properties. Co-precious stones offer different pathways for Programming interface crystallization, helping compounds with low drug profiles because of their nonionizable practical gatherings.³⁵

Supercritical fluid technology:

The drug business was quick to utilize supercritical liquid innovation for an enormous scope in the mid 1980s. During that time, drug organizations utilized SCF innovation to foster drug materials by hastening and solidifying them.²³ The SCF strategy is conservative, safe, and ecologically valuable. SCFs are engaging for drug research as a result of their low working boundaries (temperature and tension). Over its basic temperature (Tc) and strain (Pc), a SCF endures as a solitary stage.²⁴

Solid-lipid nanoparticles:

Strong lipid nanoparticles are utilized for designated drug conveyance, comprising of a hydrophobic phospholipid covering broke up in a fluid surfactant arrangement or water.^16,17,18 Strong centers in lipid lattice convey hydrophilic and hydrophobic drugs, with SLN innovation making instances of meds and generally utilized lipid excipients in nanocarriers.^19,20,21,22

Table 2: Examples of different medications created using SLN technology.

Drug	Lipid utilized
Apomorphine	Glycerylmonostearate
Calcitonine	Trimyristin
Clozapine	Trimyristin, tristearin and tripalmitine
5- Fluro uracil	Dynasan 114, Dynasan 118
Gonodropine	Monostearin
Idarubicine	Emulsifying wax
Nimesulide	Glycerylbehanate, Glycerylmonostearate
Repaglinide	Glycerylmonostearate and tristearin

Complexation:

The mind boggling comprises of at least two particles associated by a bond that frames a substance free of a particular adjusting. This is subject to moderately frail powers, for example, London powers, hydrophobic communications, and hydrogen securities.²⁴

· Stanching complexation:

Stanching buildings are regularly shaped when fragrant mixtures' covering planar spaces meet up. Solid hydrogen holding associations between the nonpolar gatherings make the H2O be taken out. The accompanying specific particles have been displayed to create stanching edifices: anthracene, benzoic corrosive, pyrene, salicylic corrosive, methylene blue, nicotinamide, ferulic corrosive, theobromine, gentisic corrosive, naphthalene, purine, and caffeine.

· Inclusion complex:

Incorporation Complexation includes adding a nonpolar molecule or visitor molecule to a host depression, guaranteeing ideal variation of visitor particles. The host depression should be sufficiently huge to hold the visitor atom and adequately little to dispense with H2O.²⁵

· Inclusion complex:

Cyclodextrin further develops dissolvability in Complexation by framing stable relationship between visitor particles. This cycle, which can be one-step or two-step, upgrades drug atoms' solvency in water. When joined with different medications, like clofibrate, rofecoxib, melarsoprol, celecoxib, cyclosporin A, and taxol, the solvency is upgraded.^{26, 27}

Manufacturing techniques for Complexation/inclusion Complexation:

· Kneading method

· Microwave irradiation method

· Co-precipitate method

· Lyophilization/freeze-drying technique

· Spray drying

Peptide Complexation:

Protein nanoparticles offer various advantages for conveying substances like development factors, peptide chemicals, prescriptions, hereditary materials, and DNA and RNA. They are steady, simple to create, and financially savvy. They have potential for in vivo use and require less synthetic compounds. Studies have shown that exemplifying curcumin in egg white protein nanoparticles lessens corruption and keeps up with cell reinforcement movement. Complexing curcumin with lysozyme upgrades antibacterial, cell reinforcement, and anticancer action.

CONCLUSION:

This audit talks about different innovations being worked on and late headways in drugs, including plan, strong molecule methods, prodrug methodologies, gem designing, micronization, nanosizing, drug forms, colloidal medication conveyance frameworks, Complexation of medications, micelle development, miniature emulsions, co solvents, polymeric micelles, drug salts, prodrug, strong state shift, delicate gel innovation, drug nanocrystals, and nanomorph hypothesis. The dissolvability improvement method is significant for definitions to satisfy helpful activity and medication bioavailability. Research is centered around demonstrating and seeing ineffectively dissolvable particles for ideal definitions.

REFERENCES:

1. Malviya VR, Pande SD, Bobade NN. Preparation and evaluation of sustained release beads of zolmitriptan hydrochloride. Research Journal of Pharmacy and Technology. 2019; 12(12):5972-6.

2. Malviya VR, Pande SD. Road CKN. Preparation ad Evaluation of Zolmitriptan Hydrochloride Lozenge. J Pharma Res. 2019; 8(8):624-9.

3. Hasan, A.A., Khudhur, H.R. and Hameed, A.K., Rheumatic autoimmune diseases: prevalence, types, causes and diagnosis. Karbala Journal of Pharmaceutical Sciences, 2022, pp no.109.

4. Osthoff, A.K.R., Juhl, C.B., Knittle, K., Dagfinrud, H., Hurkmans, E., Braun, J., Schoones, J., Vlieland, T.P.V. and Niedermann, K., 2018. Effects of exercise and physical activity promotion: meta-analysis informing the eular recommendations for physical activity in people with rheumatoid arthritis, spondyloarthritis and hip/knee osteoarthritis. Rheumatoid and Musculoskeletal Diseases, 2018, pp no .713.

5. Malviya V, Ladhake V, Gajbiye K, Satao J, Tawar M. Design and characterization of phase transition system of zolmitriptan hydrochloride for nasal drug delivery system. International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN). 2020 May 31; 13(3):4942-51.

6. Vemula, V.R., Lagishetty, V. and Lingala, S., Solubility enhancement techniques. International Journal of Pharmaceutical SciencesReviews and Research, 2010, pp no.41-51.

7. Malviya V, Thakur Y, Gudadhe SS, Tawar M. Formulation and evaluation of natural gum based fast dissolving tablet of Meclizine hydrochloride by using 3 factorial design 2. Asian Journal of Pharmacy and Pharmacology. 2020; 6(2):94-100.

8. Shinkar DM, Patil AN, Saudagar RB. Solubility and dissolution enhancement of sulfasalazine by solid dispersion technique. Research Journal of Pharmacy and Technology. 2018; 11(4):1277-82.

9. Cornelissen J, Orphan medicines and patent lawDepartment: Tilburg Law School Program: Law & Technology Master, 2019, pp no. 12.

10. Malviya V. Preparation and Evaluation of Emulsomes as a Drug Delivery System for Bifonazole. Indian journal of pharmaceutical education and research. 2021 Jan 1; 55(1):86-94.

11. Malviya VR, Tawar MG. Preparation and evaluation of oral dispersible strips of teneligliptin hydrobromide for treatment of diabetes mellitus. International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN). 2020 Jan 31; 13(1):4745-52.

12. Varandal, A.B.; Magar, D.; Saudagar, R. Different approaches toward the enhancement of drug solubility: A review. Pharmaceutical Education & Research. 2013, pp no. 415–426.

13. Reddy, A.; Parthiban, S.; Vikneswari, A.; Senthilkumar, G. A modern review on solid lipid nanoparticles as novel controlled drug delivery system. The International Journal of Research in Pharmaceutical and Nano Sciences, 2014, pp no. 313–325.

14. Severino, P.; Pinho, S.C.; Souto, E.B.; Santana, M.H. Polymorphism, crystallinity and hydrophilic–lipophilic balance of stearic acid and stearic acid–capric/caprylic triglyceride matrices for production of stable nanoparticles. Colloids Surf. B Biointerfaces 2011, pp no. 125–130.

15. Malviya V, Manekar S. Design, development and evaluation of aceclofenac and curcumin agglomerates by Crystallo Co-Agglomeration technique. Research Journal of Pharmacy and Technology. 2021; 14(3):1535-41.

16. Burange PJ, Tawar MG, Bairagi RA, Malviya VR, Sahu VK, Shewatkar SN, Sawarkar RA, Mamurkar RR. Synthesis of silver nanoparticles by using Aloe vera and Thuja orientalis leaves extract and their biological activity: a comprehensive review. Bulletin of the National Research Centre. 2021 Dec; 45:1-3.

17. Ekambaram, P.; Abdul Hasan Sathali, A.; Priyanka, K. Solid lipid nanoparticles: A review. Scientific Reviews & Chemical Communications Scientific Reviews & Chemical Communications, 2012, pp no. 80–102.

18. Westesen, K.; Bunjes, H.; Koch, M.H.J. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. The Journal of Controlled Release, 1997, pp no. 223–236.

19. Malviya V, Pande S. Development and Evaluation of Fast dissolving Film of Fluoxetine hydrochloride. Research Journal of Pharmacy and Technology. 2021; 14(10):5345-50.

20. Malviya V, Ajmire P, Manekar S, Ingle G, Burakle P. Understanding Fentanyl A Synthetic Piperidine Opioid Drug: Deciphering the Pain-Relieving Double-Edged Sword. Asian Journal of Pharmacy and Technology. 2024 May 27; 14(2):97-102.

21. Malviya V. Design and Characterization of Thermosensitive Mucoadhesive Nasal Gel for Meclizine Hydrochloride: Thermosensitive Nala Gel of Meclizine HCL. International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN). 2022 Feb 28; 15(1):5782-93.

22. Lipinski, C. Poor aqueous solubility—An industry wide problem in drug discovery. American Journal of Pharmacy. 2002, pp no. 82–85.

23. Loftsson, T.; Brewster, M.E. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. Journal of Pharmaceutical Science, 1996, pp no. 1017–1025.

24. Malviya V. Investigation of In-Vitro Antidiabetic Study, Antioxidant Activity and Anthelminthic Property of Various Extracts of Bitter Cumin Seeds: Antidiabetic Study, Antioxidant Activity, and Anthelminthic Property of Bitter Cumin Seeds. International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN). 2023 Jul 31; 16(4):6855-74.

25. Malviya V, Burange P, Thakur Y, Tawar M. Enhancement of Solubility and Dissolution Rate of Atazanavir Sulfate by Nanocrystallization. Indian Journal of Pharmaceutical Education and Research. 2021 Jul 1; 55(3):S672-80.

26. Malviya, Vedanshu, Mukund Tawar, Prashant Burange, and Rahul Jodh. "A brief review on resveratrol." (2022): 157-162.

27. Sarkar BK, Gupta AK, Jain A, Jain S. Solubility enhancement of nevirapine by polymer modification technique. Research Journal of Pharmacy and Technology. 2013; 6(9):993-5.

28. lysozyme nanoparticle enhanced its bioavailability and therapeutic efficacy in multiple cancer cells. The Journal of Molecular Liquids, 2021, pp no. 338.

29. Malviya V, Arya A, Burange P, Gajbhiye K, Rathod G, Tawar M. To evaluate the cardioprotective effect of hydroalcoholic extract of Matricaria chamomilla linn in isoproterenol induced myocardial infarction in wistar rats. Research Journal of Pharmacy and Technology. 2022; 15(9):3887-92.

30. Vemula, V.R., Lagishetty, V. and Lingala, S., Solubility enhancement techniques. International Journal of Pharmaceutical Sciences Reviews and Research, 2010, pp no.41-51.

31. Bhaduka G, Rajawat JS. Formulation development and solubility enhancement of voriconazole by solid dispersion technique. Research Journal of Pharmacy and Technology. 2020; 13(10):4557-64.

32. Malviya V, Tawar M, Burange P, Bairagi R. Preparation and Characterization of Gastroreten-tive Sustained Release In-situ Gel of Lafutidine. International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN). 2022 Dec 12; 15(6):6216-28.

33. Jadhav YL, Parashar B, Ostwal PP, Jain MS. Solid dispersion: Solubility enhancement for poorly water soluble drug. Research Journal of Pharmacy and Technology. 2012; 5(2):190-7.

34. Malviya V, Pande S. Design and Characterization of pH Dependent Phase Transition System of Almotriptan Malate for Nasal Drug Delivery System by Employing Factorial Design. Ind. J. Pharm. Edu. Res. 2024; 58(1):76-90.

35. Malviya V. Box-Behnken Modeling Served for the Development and Optimization of Nanoparticles Loaded with Perindopril and Erbumine. Asian Journal of Pharmaceutics (AJP). 2023 Sep 15; 17(03).

Received on 24.01.2024 Modified on 26.04.2024

Res. J. Pharma. Dosage Forms and Tech.2024; 16(3):221-228.

DOI: 10.52711/0975-4377.2024.00035